---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-074127"
form_type: "8-K"
ticker: "NERV"
cik: "0001598646"
company_name: "Minerva Neurosciences, Inc."
filed_at: "2022-03-14T23:59:59+00:00"
generated_at: "2026-06-26T23:13:18.836863+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Minerva Neurosciences receives Nasdaq delisting notice for equity shortfall

## Summary
- Notice received March 8, 2022: stockholders' equity in 2021 10-K fails Nasdaq Rule 5450(b)(1).
- Company has 45 days to submit a plan to regain compliance with the Rule.
- If plan accepted, Nasdaq may grant up to 180 days from notice date for evidence of compliance.
- If plan rejected or extension denied, Company may appeal to Nasdaq Hearings Panel.

## SEC filing metadata
- accession: 0001193125-22-074127
- form_type: 8-K
- ticker: NERV
- cik: 0001598646
- company_name: Minerva Neurosciences, Inc.
- filed_at: 2022-03-14T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1598646/000119312522074127/0001193125-22-074127-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1598646/000119312522074127/d316228d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-074127
- JSON: https://secwatch.observer/filing/0001193125-22-074127.json
- Plain text: https://secwatch.observer/filing/0001193125-22-074127.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.